Go to main content
Formats
Format
BibTeX
MARCXML
TextMARC
MARC
DataCite
DublinCore
EndNote
NLM
RefWorks
RIS

Files

Abstract

Suicide gene therapy is a treatment strategy designed to enhance the efficacy

of drug therapy of cancer by targeting cytotoxic drugs to the tumor but not

normal cells. It involves delivery of enzyme coding gene to tumor cells

where the expressed enzyme can convert a nontoxic prodrug molecule once

entering the cell to toxic drugs leading to apoptosis and cell suicide. The

enzyme-prodrug pairs being explored include HSV-TK/GCV, CD/5-FC,

NTR/CB1954, CYP450/Cyclophosphamide, and CPG2/CMDA. Enzyme

coding genes are cloned into plasmid or packaged into viral vectors that

facilitate gene transfer into target cells. Following prodrug administration,

cytotoxic effects are seen in all tumor cells through a mechanism of

bystander effect. The focus of this thesis is to provide a brief introduction on

cancer biology, and the treatment strategies currently available for cancer

therapy. A major emphasis will be placed on the approaches of suicide gene

therapy against cancer with detailed rationale of each approach, current

progress and future perspectives for their clinical applications.

Details

PDF

Statistics

from
to
Export
Download Full History